This on-demand webinar explores practical insights into sterile drug product development and how to select the right CDMO partner to ensure clinical and commercial success.
Webinar overview
Join our expert panel as they explore the critical success factors for selecting the right CDMO partner to support sterile fill/finish services for liquid and powder drug products. This session focuses on accelerating formulation development, navigating regulatory changes, and ensuring manufacturing readiness from early-stage development through to clinical trials.
Key topics covered
• Sterile fill/finish CDMO capabilities and service models
• Formulation development and overcoming challenges with sterile liquids and powders
• The impact of revised EU GMP Annex 1 and PUPSIT on facility design and sterility assurance
• Case study of sterile fill/finish capabilities at Upperton
Speakers
Ian Lafferty
Chief Technical Officer, Upperton Pharma Solutions